Evaluation of Proclarix in the diagnostic work‐up of prostate cancer
Abstract Objectives The use of multiparametric magnetic resonance imaging (mpMRI) has been widely adopted in the diagnostic work‐up for suspicious prostate cancer (PCa) and is recommended in most current guidelines. However, mpMRI lesions are often indeterminate and/or turn out to be false‐positive...
Main Authors: | Basil Kaufmann, Sharon Fischer, Alcibiade Athanasiou, Noémie Lautenbach, Anja Wittig, Uwe Bieri, Florian A. Schmid, Franz vonStauffenberg, Thomas Scherer, Daniel Eberli, Michael A. Gorin, Ralph Schiess, Cédric Poyet |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | BJUI Compass |
Subjects: | |
Online Access: | https://doi.org/10.1002/bco2.293 |
Similar Items
-
Cathepsin D inhibitors
by: M. Gacko, et al.
Published: (2007-11-01) -
Sequencing the Barcelona‐MRI predictive model and Proclarix for improving the uncertain PI‐RADS 3
by: Juan Morote, et al.
Published: (2024-12-01) -
The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer
by: Juan Morote, et al.
Published: (2022-04-01) -
cxsAssociation study between single nucleotide polymorphism in thrombospondins THBS1 gene and THBS2 gene and coronary artery disease in Indian population
by: Ale Eba, et al.
Published: (2024-02-01) -
The c.863A>G (p.Glu288Gly) variant of the CTSD gene is not associated with CLN10 disease
by: Juan Yang, et al.
Published: (2021-10-01)